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Aim. The conjugation of low-molecular compounds with antitumor activity to lectin and evaluation of the 
biological activity of the obtained conjugate. Methods. Organic synthesis; obtaining and analyzing Pisum 
sativum agglutinin with thiopyrano[2,3-d]thiazole derivative conjugate; its biological testing on cell cultures 
and histological samples. Results. A conjugate of the Pisum sativum lectin with the thiopyrano[2,3-d]thiazole 
derivative was obtained. Conjugation was carried out through the interaction of the aldehyde groups with the 
amino groups of lectin in the alkaline medium (pH 9.0). The compound (0.4 mg) was immobilized on lectin 
(10 mg). Conjugation of pea lectin with the antineoplastic agent led to a ~2.5-fold increase in the inhibitory 
effect tested on a L1210 mouse leukemia cells line. The anti-neoplastic effect of the studied conjugate is fully 
manifested only on the third day after the beginning of experiment, possibly after penetration of the conjugate 
into cells and its desintegration. Conclusions. The results may be used for de-velopment of new drug delivery 
systems. 
K e y w o r d s: Pisum sativum agglutinin, thiopyrano[2,3-d]thiazole, conjugate, delivery, antitumor activity.
Introduction
Lectins are proteins or glycoproteins of vegetable, mi-
crobial or animal origin that specifically bind the carbo-
hydrate structure (simple carbohydrates or glycoconju-
gates) and cause no subsequent changes, unlike the 
glycosidases. Thus, lectins are a powerful tool for 
studying carbohydrates and their derivatives in solu-
tions, as well as on the cell surface. They are widely 
used in the preparative and analytical methods in bio-
chemistry, cell biology, immunology and related scien-
tific branches, especially in the study of glycoconju-
gates. Therefore, an increasing number of investiga-
tions on the application of lectins confirms their poten-
tials in biology and medicine [1,2]. In addition, the 
promising direction of studies is the using of lectins for 
targeted delivery of drugs to specific cell types and tis-
sues. Thus, the application of drug delivery system pro-
vides the advantages over the using of non-target drugs. 
This approach is important for preventing a local action 
of drugs on the healthy tissues and enhan cing their ac-
tion towards target cells. Various drug-delivery systems 
were proposed, for example, liposomes, lipoproteins, 
microspheres, nanoparticles, etc. [3].
The idea of using lectins for drug delivery was 
first suggested in 1988 by Woodley and Naisbett 
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who proposed the applying of tomato lectin for drug 
delivery to luminal membrane of small intestine [4]. 
In 1976, the method was patented in the UK for 
treatment of dental caries based on using toothpaste 
that includes conjugates of Concanavalin A and dex-
trose [5]. The major disadvantage of lectins is their 
relatively high molecular mass. Thus, their adminis-
tration can cause various side effects in blood stream 
(allergic reactions, antibodies formation). Therefore, 
the selective binding of the lectin can be used for the 
drug delivery to tissues of the intestinal tract, rec-
tum, oral and nasal cavities, lung, eye, skin, but not 
for the direct administration into the bloodstream. 
The main advantage of lectins over the synthetic 
polymers is their biodegradability, as the proteins 
that are easily hydrolyzed by the lysosomal enzymes 
of the cells.
In order to use lectins as the transporting vector 
molecules, a biologically stable complex of lectin 
with the target drug should be created. The binding 
process can be accomplished through the specific in-
teraction of the carbohydrate structure and the active 
group of drug or via covalent binding of the drug. In 
the first case the bonds between lectins and glyco-
sides are weak, but the drug structure does not 
change. In the second case, chemical modification of 
the drug molecule and the lectin takes place, and this 
might affect the biological activity of the drug.
The purpose of our work was to perform the im-
mobilization of low-molecular weight compound to 
the lectin molecule and evaluation of the biological 
activity of the created bio-conjugate.
Materials and Methods
We used synthesized thiopyrano[2,3-d]thiazole de-
rivative as a low-molecular weight ligand for the 
conjugation to the lectin (Figure 1). In previous stud-
ies, we reported thiopyrano[2,3-d]thiazoles as po-
tential antitripanosomal, antioxidant, anticancer and 
anti-inflammatory agents [6-8]. This target com-
pound was covalently attached to the lectin of the 
pea seeds (PSA, Pisum sativum agglutinin). The lec-
tin was isolated as described previously [9]. The 
conjugation was accomplished through the interac-
tion between the aldehyde group of the target com-
pound (Les-1351K) with the amino groups of the 
proteins in the alkaline medium (pH 9.0).
Conjugation
The reaction of conjugation is based on the interac-
tion of Les-1351K aldehyde groups with lectin’s 
amino groups resulting in the formation of Shiff base 
and its subsequent reduction by sodium borohydride. 
30 mg of pea lectin were dissolved in 2.7 ml of 
0.15 M carbonate buffer (pH 9.0), split into three 
portions of 0.9 ml and various amounts of a 10 % 
solution of compound Les-1351K, dissolved in 90° 
ethanol [0.05 ml (0.5 mg); 0.1 ml (1 mg) and 0.2 ml 
(2 mg)] were added. The reaction mixture was left at 
room temperature for 48 hours, after that it was 
stopped by adding 0.1 ml of ethylene glycol to each 
sample. Then after stirring for 10 min 5 mg of sodi-
um borohydride were added to each tube. The non-
conjugated compound Les-1351K was withdrawn 
by the overnight dialysis against 50 ml of 20° etha-
nol, and then ethanol was removed by dialysis 
against 0.05 M carbonate buffer (pH 8.0). The dialy-
sis against slightly alkaline buffer solution is neces-
sary because of a better solubility of pea lectins in 
the alkaline medium.
Investigation of the obtained conjugate
The lectin activity (an ability to bind the specific 
carbohydrates and glycoproteins of the cell memb-
rane), and the total protein and Les-1351K compound 
content are the important characteristics of the 
obtained conjugate. The lectin activity before and 
after conjugation was measured by determining the 
agglutination titer of 2 % suspension of the group A 
human erythrocytes in the buffered saline, as des-
cribed previously [1]. The content of the target Les-
1351K compound in 1 mg of conjugate was mea-
sured by absorbance assay at 310 nm with formulae: 
C%= (A310 х K─ A310L x CPSA) х 100 %, where A310 
is the absorbance of conjugate, A310L is the absor ban-
ce of lectin, K = 0,094 as coefficient of increasing of 
extinction per unit concentration, CPSA = content of 
lectin. The protein concentration in the pea lectin so-
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lution was also measured spectrophotometrically at 
740 nm by Lowri method. In parallel we determined 
hemagglutination titer by rabbit erythrocytes for the 
measurement concentration of lectin (1 % PSA has 
titer rabbit agglutination in 1 : 2048).
Synthesis of 7-{2-[(2-chlorobenzyl)oxy]-5-nit-
ro phe nyl}-2-oxo-3,5, 6,7-tetrahydro-2H-thiopy ra-
no[2,3-d][1,3]thiazole-6-carbaldehyde (Les-1351) 
was performed as described previously [10]. Target 
derivative Les-1351K was obtained via reaction of 
Les-1351 and potassium hydroxide in ethanol me-
dium.
 
Fig.1. Structure of 
the investigated 
thio py rano[2,3-d]
thiazole ‒ com-
pound Les-1351K
Cell culture
The murine leukemia cells of L 1210 line were ob-
tained from Cell culture collection of R. E. Kavetsky 
Institute of Experimental Pathology, Oncology and 
Radiobiology, National Academy of Sciences of 
Ukraine. Cells were cultured in the Dulbecco’s 
modified Eagle’s medium (DMEM, Sigma Chem. 
Co, St. Louis, USA) supplemented with 10 % fetal 
bovine serum (Sigma), 50 µg/ml streptomycin 
(“Sigma”) and phenol red used as pH indicator. The 
color change from yellow to red can indicate the cell 
viability. To determine the cytotoxic action of the 
Pisum sativum lectin, Les-1351K compound and 
their conjugate on the cells cultured were sown in 
96-well plastic plates in DMEM medium supple-
mented with 10 % fetal bovine serum, and the tested 
substances in different concentrations were added. 
Doxorubicin (Ukraine) was used as a positive con-
trol. The counting of cell number was carried out 
usin g Phenol Red dye (DV-T10282, Invitrogen, 
USA) at different intervals in the hemocytometric 
chamber. The dead cells uptake this dye to the dam-
age of their plasma membrane. Thus, the cells co lo-
red in blue are pronecrotic ones. Cell density in sus-
pension was counted using the following formula: 
c=12500n, where: c – number of cells in 1 ml of sus-
pension, n – average number of cells in 5 large 
squares of the hemocytometer.
Histological study
For histological study, the autopsy material of hu-
man colon was used. The histological specimens 
were fixed in formalin, then washed, and dehydrated 
in the ascending alcohols, lighted in xylene and 
embedded in the paraffin wax. For tissue morphology 
study, 5- to 7-μm-thick sections were stained with 
Hematoxylin and Eosin using known procedure.
The preparation of the Pisum sativum lectin 
labelled with colloidal gold
To detect carbohydrate determinants of the pea lec-
tin conjugate, the labelling with colloidal gold was 
used. The 15 nm colloidal gold particles were pre-
pared as described previously [11]. Synthesis of col-
loidal gold particles was performed by reducing 
0.01 % HAuCl4 with potassium citrate dihydrate. 
Concentration of the particles was determined by 
measuring the extinction of colloid solution at 
A520 nm. 0.25 ml of 10 % solution polyvinylpyrrol-
idone (Mw = 24 kDa) and 5.0 ml of 0.1 M acetate 
buffer (pH 6.0) were added to 50 ml of colloidal gold 
(A520 = 5.0) for stabilization. To resulting colloid, 
the pea lectin in the same acetate buffer was added. 
The amount of introduced lectin was determined ex-
perimentally by using non-stabilized (without poly-
vinylpyrrolidone) gold particles.
Detection of lectin binding in cells
The histological sections were prepared according to 
the standard protocol and proved after dewaxing 
with water, then incubated for 60 min in a solution of 
gold-labeled Pisum sativum lectin at room tempera-
ture. After washing the non-conjugated lectins a so-
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lution of silver acetate in the hydroquinone develo-
per prepared in 0.1 M citrate buffer (pH 3.5) was 
added. Such treatment is needed in order to make the 
gold particles invisible under the light microscope 
when imaging is amplified by the silver salts [12]. 
Accumulation of the metallic silver occurs in the 
sites of localisation of colloidal gold particles that 
are clearly visible under the light microscope (simi-
lar to silver impregnation). The process was con-
trolled under the microscope in order to avoid an 
excessive accumulation of silver. The displaying 
process with silver acetate was performed for 10–
15 min.
Results and Discussion
Solubility of lectins in water or in the medium where 
denaturation of proteins does not proceed is an im-
portant condition for effective ligand binding. These 
media include water-saline solutions with alcohol of 
different concentration (20–30 %) or other organic 
solvents (such 20–30 % DMSO solution). The Les-
1351K is soluble in DMSO, ethanol and water-etha-
nol mixtures that facilitates obtaining of conjugates. 
Besides, the presence of the aldehyde group in struc-
ture of the target compound makes possible the at-
tachment of the proteins under soft conditions with-
out their denaturation. According to the calculations, 
10 mg of lectin conjugate contain approximately 
0.4 mg of the studied compound (4 % of the total 
conjugate weight). The obtained conjugate was solu-
ble in water, 30 % DMSO, but insoluble in the or-
ganic solvents. A high level of the compound Les-
1351K in the conjugate can cause a loss of its solu-
bility and formation of the precipitate.
The results of cytotoxicity measuring of the ob-
tained conjugate towards the murine leukemia 
L1210 cell line are depicted in Fig. 2. The color 
changing of phenol red in well plates from yellow to 
 
Fig. 2. The effect of 
pea lectin, doxorubi-
cin, Les-1351K, and 
Les-1351K conjugate 
with pea lectin to-
wards murine leuke-
mia L1210 cells after 
72-h treatment (Ac-
cording to the Phenol 
Red test)
Fig. 3. The effect of Les-1351K and Les-1351K conjugate with 
the pea lectin towards the murine leukemia L1210 cell line (cal-
culated for pure Les-1351K, according to the Phenol Red test).
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red indicates the appearance of dead cells. As a re-
sult, Les-1351K displays high level of the antineo-
plastic activity, although it was 10 times less than 
that of the doxorubicin. The pea lectin (10 mg/ml) 
was completely non-toxic for the murine leukemia 
L1210 cells. The conjugate of pea lectin with Les-
1351K in 10 mg/ml concentration displays the same 
action as Les-1351K in 1 mg/ml dose. As a result, 
the activity of studied compound increased more 
than 2.5 fold after its conjugation with the pea lectin.
While the murine leukemia L1210 cells growing 
in suspension culture were dying under the action of 
both Doxorubicin and Les-1351K, the cytotoxic ef-
fect of these agents towards the human embryonic 
kidney HEK-293 cells growing in a monolayer cul-
ture (attached) was less expressed, especially in the 
case of cell treatment with Les-1351K (Fig.4). This 
compound did not affect the human breast carcino-
ma MCF-7 cells (epithelial origin) also growing in 
the monolayer culture. Doxorubicin was cytotoxic 
for the MCF-7 cells, although to much lower extent 
than for the leukemia L1210 cells and the pseudo-
normal HEK-293 cells. 
An important factor for increasing the toxicity to-
wards the murine leukemia L1210 cells is a selective 
binding of the cytotoxic agent with the carbohydrate-
containing receptors on a cell surface, including tis-
sues containing the cells of different types. Notably, 
the action of Les-1351K-lectin conjugate was well 
manifested only on the third day after the start of the 
experiment. Thus, Les-1351K initially penetrated 
into the cell, disconnected from the conjugate, and 
then expressed their activity. Penetration of the lec-
tin conjugate into the cells might occur by the pino-
cytosis, as it happens with free lectins. Ligand’s re-
lease in the cells could be carried out by the lyso-
somal enzymes, as it occurs at the release of other 
proteins.
It should be noted that EC50 for Les 1351K and 
Les-1351K conjugate are integral index that depend-
ed on the duration of the experiment. The data of 
these experiments is presented in table 1
The staining of the colon with the pea lectin la-
beled with colloidal gold was performed. A selectiv-
ity of binding this substance with several histologi-
cal structures was found, especially with the mucin 
of the goblet cells (including the membrane vesicles) 
(Figure 5). 
The use of colon as tissue for the interaction of its 
cells with the pea lectin demonstrated that the inner 
surface of the intestinal tract possesses the binding 
sites for the conjugate. In particular, administration 
of such conjugate to the ointment or suppository ba-
sis could be promising for the treatment of rectal 
cancer. For example, in our previous investigation it 
was found that the lectin from carp roe and Phaseolus 
vulgaris erythroagglutinin were not bound by nor-
mal colon tissue, however, higher affinity of these 
Table 1. Value of EC50 for Les-1351K-conjugate in dependent on the duration of the experiment
EC50, μg/ml 24 h 48 h 72 h
Phenol red (cytotoxicity testing) ~ 10 ~ 8,3 4,4
MTT (metabolic testing) ≥ 10 7,8 3,4
Fig. 4. The effect of Les-1351K and doxorubicin on the murine 
leukemia L1210, human embryonic kidney HEK-293 and hu-
man breast carcinoma MCF-7 cells.
* P<0.05, ** P<0.01
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lectins to well differentiated colon adenocarcinomas 
was demonstrated [13]. The conjugation of these 
lectins with Les-1351K can be performed by using 
the described method.
Lectins possess certain limitations of their using 
as drugs (see “Introduction”). Thus, they should be 
used only for external application, in particular, at 
the treatment of the diseases of skin, intestinal tract, 
nasal cavity, lung or as a basis of various rinses and 
sprays, suppositories and ointment bases, but not for 
administration through the bloodstream. The ob-
tained results revealed that the lectins application 
could be a perspective model for developing ligand-
targeted drugs. Thus, the creation of more effective 
drugs with a higher concentration of active ingredi-
ents in some histological structures is an important 
approach in medicinal chemistry.
Conclusions
1.  The investigation of the interaction of the pea lec-
tin conjugate with the anticancer agent Les-1351K 
revealed a 2.5 fold increasing of the antineoplastic 
activity of this compound towards the murine leu-
kemia L1210 cell line.
2.  The enhancement of action of the conjugate to-
wards the target cells could be explained by se-
lective binding of the glycoconjugate with the 
cell surface which is provided by lectin’s compo-
nent in the conjugate. The antineoplastic activity 
of the tested conjugate is observed on the third 
day, probably after the accomplishment of the 
conjugate into the target cells and the decompo-
sition of the conjugate with a release of the anti-
cancer agent.
3.  The obtained results are of interest for elaboration 
of novel drug delivery systems.
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Використання лектину як векторної молекули для 
доставки лікарських засобів до клітин і тканин
В. О. Антонюк, О. Ю. Ключівська, Р. В. Антонюк, 
А. В. Лозинський, Х. Р. Погранична, Р. Б. Лесик, 
Р. С. Стойка
Мета. Приєднання низькомолекулярної сполуки з протипух-
линною активністю до лектину та визначення біологічної ак-
тивності одержаного кон’юґату. Методи. Органічний синтез; 
одержання та аналіз кон’юґату лектину гороху з похідним 
тіопірано[2,3-d]тіазолу, біотестування кон’югату на культурі 
клітин та гістологічних препаратах. Результати. Одержано 
кон’югат лектину гороху (Pisum sativum) приєднаним похід-
ним тіопірано[2,3-d]тіазолу. Кон’югацію здійснювали через 
взаємодію альдегідної групи сполуки похідного з аміногрупа-
ми білка лектину в лужному середовищі (рН 9,0). До 10 мг лек-
тину було приєднано ≈ 0,4 мг досліджуваної сполуки. 
Кон’юґація лектину гороху з протипухлинною речовиною 
спричинила підсилення інгібувальної дії останньої на клітини 
лінії L1210 лейкозу миші приблизно у 2,5 рази (у перерахунку 
на речовину). Антинеопластична дія кон’югату в повній мірі 
проявляється лише на третю добу від початку досліду, й імо-
вірно після проникнення кон’юґату у клітину і розпаду молеку-
ли. На гістологічному препараті визначено особливості 
зв’язування досліджуваного кон’югату з мукозними клітинами 
прямої кишки людини. Висновки. Одержані результати мо-
жуть бути цікавими для моделювання адресної доставки біо-
логічно активних речовин в клітини тканин організму.
К л юч ов і  с л ов а: Pisum sativum agglutinin, тіопірано[2,3-d]
тіазоли, кон’юґат, доставка, протипухлинна активність.
Использование лектина как векторной молекулы для 
доставки лекарственных средств в клетки и ткани.
В. О. Антонюк, О. Ю. Ключивская, Р. В. Антонюк, 
А. В. Лозинский, Х. Р. Погранычна, Р. Б. Лесык, 
Р. С. Стойка
Цель. присоединение низкомолекулярного соединения с проти-
воопухолевой активностью к лектину и проверка биологической 
активности полученного конъюгата. Методы. Органический син-
тез; получение и анализ конъюгата лектина гороха с производным 
тиопирано[2,3-d]тиазола, биотестирование конъюгата на культу-
ре клеток и гистологических препаратах. Результаты. Получен 
конъюгат лектина гороха (Pisum sativum) с присоединенным про-
изводным тиопирано[2,3-d]тиазола. Конъюгацию осуществляли 
через взаимодействие альдегидной группы соединения производ-
ного с аминогруппами белка лектина в щелочной среде (рН 9,0). 
К 10 мг лектина было присоединено ≈ 0,4 мг исследуемого соеди-
нения. Конъюгация лектина гороха с противоопухолевым веще-
ством вызвала усиление ингибирующего действия вещества на 
клетки линии L1210 лейкоза мыши примерно в 2,5 раза (в пе-
ресчете на вещество). Антинеопластическое действие конъюгата 
в полной мере проявляется лишь на третьи сутки от начала опыта, 
и вероятно после проникновения конъюгата в клетку и распада 
молекулы. На гистологическом препарате определены особенно-
сти связывания исследуемого конъюгата с мукозными клетками 
прямой кишки человека Выводы. Полученные результаты пред-
ставляют интерес для моделирования адресной доставки биоло-
гически активных веществ в клетки тканей организма.
К л юч е в ы е  с л ов а: Pisum sativum agglutinin, тиопира-
но[2,3-d]тиазолы, конъюгаты, доставка, противоопухолевая 
активность.
Received 01.10.2016
